Digital Media briefs
FDA launched a Twitter profile focused specifically on prescription drugs. The agency said it will use the application to provide “timely information on new drug approvals, safety alerts, compliance actions and consumer information.” FDA will not respond to replies or direct messages, the agency said in an online disclaimer.
The Stanford University School of Medicine joined the University of Philadelphia, the Cleveland Clinic and others in a decision to publicly disclose information about the consulting activities of its 1,400 affiliated faculty. As of August, faculty profiles on the school's website will include information about any consulting relationships with specific companies.